The rise of Viagra initially drove a period of growth for pharma, nevertheless recent changes present a murky outlook for shareholders. Generic alternatives are eating into earnings, and ongoing legal battles add https://karimlebo365173.post-blogs.com/62033415/the-blue-pill-and-pharma-a-risky-investment